Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07275879

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS).

SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life.

Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Luke's Clinical Hospital

Saint Petersburg, Outside U.S./Canada, Russia

Location status: Recruiting

Location contact

Dmitriy Sytnik

CONTACT

[email protected]

+7 931 367 78 58

About this study

Study Design:

Prospective, randomized, open-label, controlled trial with two parallel arms.

Study Center:

Department of Urology, St. Luke's Clinical Hospital, St. Petersburg, Russia

Study Population:

All patients should not be prestented and should have no ureteral obstruction. 40 patients, divided into four equal groups of 20 people each:

Group I (standard DJ stent):

Group II (modified DJ stent)

Procedure for evaluation:

After surgery ( RIRS, ureteroscopy) reflux is assessed (gravity-filling cystogram). After stenting, the presence of post-stent reflux is assessed.

In the postoperative period, patients complete the USSQ (1st day, 7th day and before stent removal).

Statistics method:

The results are presented as the median and interquartile range (IQR) for continuous variables, and as frequencies (n with percentage %) for categorical variables. Statistical comparisons of all primary and secondary outcome measures between different treatment groups were conducted using the Mann-Whitney U test for continuous data. Meanwhile, categorical variables were analyzed using either Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Thenthreshold for statistical significance was established at 5%, implying that a p-value less than 0.05 (p < 0.05) was considered statistically significant for all tests performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years and older
  • Patients with kidney stones
  • Patients with ureteral stones

Exclusion criteria

  • Congenital anomalies of the urinary tract
  • Urinary tract infections
  • Upper urinary tract obstruction
  • Complicated ureteroscopy (e.g., ureteral perforation)
  • Pregnancy
  • Pre-stented patients

Treatment and study plan

Ureteric stent insertion

Procedure

Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting

Primary outcomes

  1. ureteral reflux

    Time frame: Intraoperative

    Injection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.

  2. Assessment the Ureteral Stent Symptom Questionnaire (USSQ)

    Time frame: Postoperative: 1st and 7th day, before stent removal

    Ureteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents.

    USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains:

    Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.

Secondary outcomes

  1. Patient's height

    Time frame: Preoperative

    The patient's height is measured in centimeters.

  2. Patient's weight

    Time frame: Preoperative

    The patient's weight is measured in centimeters.

  3. Body mass index (BMI)

    Time frame: Preoperative

    Body mass index (BMI) is a value derived from the mass (weight) and height of a person.

    BMI = kg/m2

  4. Operative time

    Time frame: Intraoperative (measured from start to end of procedure)

    total operative time in minutes

  5. Surgery

    Time frame: Preoperative

    Type of surgery: ureteroscopy or retrograde intrarenal surgery or stenting

Study contacts

Contact information is provided by the study sponsor or research team.

Dmitriy Sytnik

CONTACT

[email protected]

+7 931 367 78 58

Yury Mikheev

CONTACT

[email protected]

+79315412190

Sponsors and collaborators

Lead sponsor

St. Luke's Clinical Hospital, Russia

Other

Registry information

Official study title

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent. Randomized Clinical Trial.

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 10, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.